Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00278447 · ClinicalTrials.gov registry record · Phase 3
Addiction Health Evaluation And Disease Management (AHEAD) Study
A Phase 3 study, sponsored by Boston Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 569
- Enrollment target
NCT00278447: Completed Phase 3 study, sponsored by Boston Medical Center.
NCT00278447 is a Phase 3 study that has completed, run by Boston Medical Center. The registered enrollment target is 569 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (26% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00278447, a Phase 3 study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 569 participants
- Enrollment target
Study Summary
The objective of this study is to test whether a chronic disease management (CDM) program for substance abusers in primary care leads to improved alcohol and drug-related outcomes (such as reduced consumption and health problems) and health care utilization patterns.
Interventions
- BEHAVIORAL Standard care
- BEHAVIORAL Chronic Disease Management for substance abuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 569 participants |
| Start Date | 2006-04 |
| Est. Completion | 2012-04 |
| Phase | Phase 3 |
What the finished NCT00278447 record still lists
NCT00278447 is an interventional study that assigns participants to a tested intervention. The registered 569 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (26% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard care is the first listed.
NCT00278447 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00278447 about?
NCT00278447 is a clinical study titled "Addiction Health Evaluation And Disease Management (AHEAD) Study". The objective of this study is to test whether a chronic disease management (CDM) program for substance abusers in primary care leads to improved alcohol and drug-related outcomes (such as reduced consumption and health problems) and health care utilization patterns.
What is the current status of trial NCT00278447?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 569 participants. The study started on 2006-04. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00278447?
The interventions under investigation include: Standard care (BEHAVIORAL), Chronic Disease Management for substance abuse (BEHAVIORAL).
Who is sponsoring clinical trial NCT00278447?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00278447's enrollment target sits among peer trials
569 666th of 2000 higher than 1,335 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05000645 · 570 participants · NA
Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women
- NCT06239844 · 570 participants · NA
Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English
- NCT06701903 · 570 participants · Phase 2
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
- NCT07266831 · 570 participants · Phase 2
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia